Molecular Epidemiology of Hepatitis C virus in Prishtina region of Kosovo [Molekularna epidemiologija virusa Hepatitisa C u regiji Priština na Kosovu]

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  2018-12-19

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries

  2018cited by this paper
• ICTV Virus Taxonomy Profile: Flaviviridae

  2017cited by this paper
• Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

  2017cited by this paper
• HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar

  2017cited by this paper
• Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.

  2017cited by this paper
• Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes

  2016cited by this paper
• Hepatitis C Virus

  2016cited by this paper
• APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing

  2016cited by this paper
• Hepatitis C Virus Outbreaks in Hemodialysis Centers: A Continuing Problem

  2016cited by this paper
• New findings in HCV genotype distribution in selected West European, Russian and Israeli regions.

  2016cited by this paper
• Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China’s National Methadone Maintenance Treatment Program

  2016cited by this paper
• Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe

  2016cited by this paper
• Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling survey

  2015cited by this paper
• Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients

  2015cited by this paper
• Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.

  2015cited by this paper
• Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal

  2015cited by this paper
• Hepatitis C virus genotypes in Tirana, Albania.

  2014cited by this paper
• Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada

  2014cited by this paper
• Prevention of infectious diseases among people who inject drugs in some Western Balkan countries

  2014cited by this paper
• Prevalence of Hepatitis C Virus in the Population of Albania for the Period 2007-2010

  2014cited by this paper
• Management of hepatitis C virus infection in hemodialysis patients.

  2014cited by this paper
• Trends in hepatitis C infection among hemodialysis patients in Senegal: results of a decade of prevention.

  2014cited by this paper
• Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections

  2014cited by this paper
• Hepatitis C Virus Genotype 7, a New Genotype Originating from Central Africa

  2014cited by this paper
• Distribution of hepatitis C virus genotypes among injecting drug users in Albania

  2014cited by this paper
• Global Distribution and Prevalence of Hepatitis C Virus Genotypes

  2014cited by this paper
• Risk Behaviors, Prevalence of HIV and Hepatitis C Virus Infection and Population Size of Current Injection Drug Users in a China-Myanmar Border City: Results from a Respondent-Driven Sampling Survey in 2012

  2014cited by this paper
• Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission.

  2014cited by this paper
• Viral hepatitis C and B among dialysis patients at the Rabat University Hospital: prevalence and risk factors.

  2014cited by this paper
• The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis

  2013cited by this paper
• Prevalence of hepatitis C virus infection and genotypes in patient with chronic kidney disease undergoing hemodialysis

  2013cited by this paper
• Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource

  2013cited by this paper
• Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

  2013cited by this paper
• Molecular epidemiology of hepatitis C virus genotypes and subtypes among injecting drug users in Hungary.

  2013cited by this paper
• Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: A multicenter study in Beijing, China

  2013cited by this paper
• The origin of hepatitis C virus.

  2013cited by this paper
• Viral hepatitis and the Global Burden of Disease: a need to regroup

  2013influential reference
• Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study

  2012cited by this paper
• Epidemiology of end‐stage renal disease and hemodialysis treatment in Serbia at the turn of the millennium

  2012cited by this paper
• Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors

  2012cited by this paper
• Treating hepatitis C: current standard of care and emerging direct‐acting antiviral agents

  2012cited by this paper
• Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs

  2012cited by this paper
• Hepatitis C in hemodialysis: epidemiology and prevention of hepatitis C virus transmission.

  2012cited by this paper
• Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.

  2011cited by this paper
• IL28B Genomic-Based Treatment Paradigms for Patients With Chronic Hepatitis C Infection: The Future of Personalized HCV Therapies

  2011cited by this paper
• Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal

  2011cited by this paper
• Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users

  2011cited by this paper
• Assembly of infectious hepatitis C virus particles.

  2011cited by this paper
• What Is Killing People with Hepatitis C Virus Infection?

  2011cited by this paper
• Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

  2011cited by this paper
• Adequacy of dialysis clinic staffing and quality of care: a review of evidence and areas of needed research.

  2011cited by this paper
• MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

  2011cited by this paper
• Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs

  2011cited by this paper
• Hepatitis C virus antibody status, sociodemographic characteristics, and risk behaviour among injecting drug users in Croatia.

  2011cited by this paper
• Hepatocellular carcinoma: a global view

  2010influential reference
• How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides.

  2010cited by this paper
• Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.

  2010cited by this paper
• HIV in people who use drugs 1 HIV and risk environment for injecting drug users : the past , present , and future

  2010influential reference
• Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.

  2010cited by this paper
• Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

  2010cited by this paper
• New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0.

  2010cited by this paper
• An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.

  2010cited by this paper
• HEALTH and HUMAN SERVICES

  2010cited by this paper
• Prevalence of HBV and HCV among blood donors in Kosovo

  2009cited by this paper
• Screening for hepatitis B, C and HIV infection among patients on haemodialysis (cross sectional analysis among patients from two dialysis units in the period January to July 2005).

  2009cited by this paper
• Viral hepatitis, HIV, human herpes virus and Treponema pallidum infection in haemodialysis patients from Kosovo, 2005.

  2009cited by this paper
• Hepatitis B and C in dialysis units in Kosova

  2009cited by this paper
• Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

  2009cited by this paper
• HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality

  2009cited by this paper
• Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia

  2009cited by this paper
• IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

  2009cited by this paper
• Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

  2009cited by this paper
• A shield against a monster: Hepatitis C in hemodialysis patients.

  2009cited by this paper
• Hepatitis C virus-induced hepatocarcinogenesis.

  2009cited by this paper
• Transmission of hepatitis C genotypes in the Netherlands amongst recently genotyped patients.

  2008influential reference
• Acute hepatitis C: current status and remaining challenges.

  2008cited by this paper
• Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy

  2008cited by this paper
• Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha.

  2008cited by this paper
• The changing epidemiology of hepatitis C virus infection in Europe.

  2008cited by this paper
• Infectivity of Hepatitis C Virus in Plasma After Drying and Storing at Room Temperature

  2007cited by this paper
• The hepatitis C sequence database in Los Alamos

  2007cited by this paper
• Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report.

  2007cited by this paper
• Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.

  2007cited by this paper
• The importance of social networks in their association to drug equipment sharing among injection drug users: a review.

  2007influential reference
• Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors.

  2006influential reference
• Distribution of hepatitis C virus genotypes in Croatia--a 10 year retrospective study of four geographic regions.

  2006cited by this paper
• Hepatitis C infection in risk groups.

  2006cited by this paper
• Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada

  2006cited by this paper
• Distribution of HCV Genotypes in Patients with End-Stage Renal Disease According to Type of Dialysis Treatment

  2006cited by this paper
• [Hepatitis virus infection among hemodialysis patients].

  2005cited by this paper
• HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece.

  2005cited by this paper
• Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Blood Donors from Southeast France

  2005cited by this paper
• Geographic distribution of hepatitis C virus genotypes in Brazil.

  2005cited by this paper
• Chronic Hepatitis C and Genotyping: The Clinical Significance of Determining HCV Genotypes

  2005cited by this paper
• Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

  2004cited by this paper
• The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study.

  2004cited by this paper
• Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

  2004cited by this paper
• [Genetic variations of hepatitis C virus circulating in the Ural region].

  2003cited by this paper
• Modified Range of Alanine Aminotransferase is Insufficient for Screening of Hepatitis C Virus Infection in Hemodialysis Patients

  2002cited by this paper
• Sharing of drug preparation equipment as a risk factor for hepatitis C.

  2001cited by this paper

• No citing papers are available for this paper.